On January 30, 2012, Helix Biopharma Corp issued a press release announcing that its annual general meeting was held as scheduled. In addition, the Company stated that the current board of directors will continue in their position until the new meeting. Further, the Company stated that the chairman of the annual meeting expressed his concerns that shareholders had not been properly and fully informed in making their voting decisions with respect to the election of directors and the proxies have been solicited through misrepresentations, hence there needs to be a new solicitation process and subsequent shareholder vote with respect to the election of directors at a new meeting of shareholders. As well as, the Company stated that the new meeting should not be delayed unnecessarily and ought to be called within 3 months at the latest.